adesso SE
adesso SE (ADN1.DE) Stock Competitors & Peer Comparison
See (ADN1.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Information Technology Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ADN1.DE | €58.90 | +2.97% | 370M | 27.79 | €2.08 | +1.30% |
| IBM.DE | €211.20 | +1.13% | 194.5B | 21.45 | €9.67 | +2.77% |
| FIV.DE | €48.19 | +1.40% | 25.9B | 8.79 | €5.50 | N/A |
| COZ.DE | €53.06 | -0.49% | 25.4B | 13.44 | €3.95 | +2.06% |
| 6WS.SG | €10.43 | +0.19% | 13.4B | N/A | N/A | N/A |
| BC8.DE | €29.96 | +8.00% | 3.7B | 17.05 | €1.71 | +2.40% |
| 4018.F | €1,245.00 | -0.40% | 2B | -113.39 | -€10.98 | N/A |
| 217A.F | €7.45 | +6.43% | 1.9B | -59.58 | -€0.12 | N/A |
| CHG.DE | €33.90 | +9.35% | 774.1M | -34.74 | -€0.95 | N/A |
| COK.DE | €24.70 | +1.86% | 735.9M | 43.91 | €0.55 | +4.14% |
Stock Comparison
ADN1.DE vs IBM.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, IBM.DE has a market cap of 194.5B. Regarding current trading prices, ADN1.DE is priced at €58.90, while IBM.DE trades at €211.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas IBM.DE's P/E ratio is 21.45. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to IBM.DE's ROE of +0.37%. Regarding short-term risk, ADN1.DE is more volatile compared to IBM.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check IBM.DE's competition here
ADN1.DE vs FIV.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, FIV.DE has a market cap of 25.9B. Regarding current trading prices, ADN1.DE is priced at €58.90, while FIV.DE trades at €48.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas FIV.DE's P/E ratio is 8.79. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to FIV.DE's ROE of +0.14%. Regarding short-term risk, ADN1.DE is more volatile compared to FIV.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check FIV.DE's competition here
ADN1.DE vs COZ.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, COZ.DE has a market cap of 25.4B. Regarding current trading prices, ADN1.DE is priced at €58.90, while COZ.DE trades at €53.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas COZ.DE's P/E ratio is 13.44. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to COZ.DE's ROE of +0.15%. Regarding short-term risk, ADN1.DE is more volatile compared to COZ.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check COZ.DE's competition here
ADN1.DE vs 6WS.SG Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, 6WS.SG has a market cap of 13.4B. Regarding current trading prices, ADN1.DE is priced at €58.90, while 6WS.SG trades at €10.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas 6WS.SG's P/E ratio is N/A. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to 6WS.SG's ROE of +0.27%. Regarding short-term risk, ADN1.DE is more volatile compared to 6WS.SG. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check 6WS.SG's competition here
ADN1.DE vs BC8.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, BC8.DE has a market cap of 3.7B. Regarding current trading prices, ADN1.DE is priced at €58.90, while BC8.DE trades at €29.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas BC8.DE's P/E ratio is 17.05. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to BC8.DE's ROE of +0.12%. Regarding short-term risk, ADN1.DE is more volatile compared to BC8.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check BC8.DE's competition here
ADN1.DE vs 4018.F Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, 4018.F has a market cap of 2B. Regarding current trading prices, ADN1.DE is priced at €58.90, while 4018.F trades at €1,245.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas 4018.F's P/E ratio is -113.39. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to 4018.F's ROE of +0.07%. Regarding short-term risk, ADN1.DE is more volatile compared to 4018.F. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check 4018.F's competition here
ADN1.DE vs 217A.F Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, 217A.F has a market cap of 1.9B. Regarding current trading prices, ADN1.DE is priced at €58.90, while 217A.F trades at €7.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas 217A.F's P/E ratio is -59.58. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to 217A.F's ROE of -0.04%. Regarding short-term risk, ADN1.DE is more volatile compared to 217A.F. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check 217A.F's competition here
ADN1.DE vs CHG.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, CHG.DE has a market cap of 774.1M. Regarding current trading prices, ADN1.DE is priced at €58.90, while CHG.DE trades at €33.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas CHG.DE's P/E ratio is -34.74. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to CHG.DE's ROE of -0.10%. Regarding short-term risk, ADN1.DE is less volatile compared to CHG.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ADN1.DE.Check CHG.DE's competition here
ADN1.DE vs COK.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, COK.DE has a market cap of 735.9M. Regarding current trading prices, ADN1.DE is priced at €58.90, while COK.DE trades at €24.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas COK.DE's P/E ratio is 43.91. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to COK.DE's ROE of +0.05%. Regarding short-term risk, ADN1.DE is more volatile compared to COK.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check COK.DE's competition here
ADN1.DE vs USY1.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, USY1.DE has a market cap of 700.6M. Regarding current trading prices, ADN1.DE is priced at €58.90, while USY1.DE trades at €10.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas USY1.DE's P/E ratio is -2.10. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to USY1.DE's ROE of +5.17%. Regarding short-term risk, ADN1.DE is more volatile compared to USY1.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check USY1.DE's competition here
ADN1.DE vs NA9.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, NA9.DE has a market cap of 621.1M. Regarding current trading prices, ADN1.DE is priced at €58.90, while NA9.DE trades at €46.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas NA9.DE's P/E ratio is 12.54. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to NA9.DE's ROE of +0.26%. Regarding short-term risk, ADN1.DE is less volatile compared to NA9.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ADN1.DE.Check NA9.DE's competition here
ADN1.DE vs D6H.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, D6H.DE has a market cap of 613.8M. Regarding current trading prices, ADN1.DE is priced at €58.90, while D6H.DE trades at €76.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas D6H.DE's P/E ratio is 28.03. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to D6H.DE's ROE of +0.14%. Regarding short-term risk, ADN1.DE is more volatile compared to D6H.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check D6H.DE's competition here
ADN1.DE vs SHF.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, SHF.DE has a market cap of 587.5M. Regarding current trading prices, ADN1.DE is priced at €58.90, while SHF.DE trades at €80.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas SHF.DE's P/E ratio is 18.44. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to SHF.DE's ROE of +0.22%. Regarding short-term risk, ADN1.DE is more volatile compared to SHF.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check SHF.DE's competition here
ADN1.DE vs NA9.F Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, NA9.F has a market cap of 584.6M. Regarding current trading prices, ADN1.DE is priced at €58.90, while NA9.F trades at €46.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas NA9.F's P/E ratio is 11.76. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to NA9.F's ROE of +0.26%. Regarding short-term risk, ADN1.DE is less volatile compared to NA9.F. This indicates potentially lower risk in terms of short-term price fluctuations for ADN1.DE.Check NA9.F's competition here
ADN1.DE vs NB2.F Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, NB2.F has a market cap of 558.8M. Regarding current trading prices, ADN1.DE is priced at €58.90, while NB2.F trades at €8.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas NB2.F's P/E ratio is -3.94. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to NB2.F's ROE of -0.46%. Regarding short-term risk, ADN1.DE is more volatile compared to NB2.F. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check NB2.F's competition here
ADN1.DE vs NA9.SG Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, NA9.SG has a market cap of 558.1M. Regarding current trading prices, ADN1.DE is priced at €58.90, while NA9.SG trades at €46.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas NA9.SG's P/E ratio is N/A. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to NA9.SG's ROE of +0.26%. Regarding short-term risk, ADN1.DE is less volatile compared to NA9.SG. This indicates potentially lower risk in terms of short-term price fluctuations for ADN1.DE.Check NA9.SG's competition here
ADN1.DE vs DE000A3H2200.SG Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, DE000A3H2200.SG has a market cap of 556.8M. Regarding current trading prices, ADN1.DE is priced at €58.90, while DE000A3H2200.SG trades at €44.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas DE000A3H2200.SG's P/E ratio is N/A. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to DE000A3H2200.SG's ROE of +0.00%. Regarding short-term risk, ADN1.DE is more volatile compared to DE000A3H2200.SG. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check DE000A3H2200.SG's competition here
ADN1.DE vs NB2.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, NB2.DE has a market cap of 546.6M. Regarding current trading prices, ADN1.DE is priced at €58.90, while NB2.DE trades at €8.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas NB2.DE's P/E ratio is -3.85. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to NB2.DE's ROE of -0.46%. Regarding short-term risk, ADN1.DE is more volatile compared to NB2.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check NB2.DE's competition here
ADN1.DE vs GFT.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, GFT.DE has a market cap of 462.3M. Regarding current trading prices, ADN1.DE is priced at €58.90, while GFT.DE trades at €18.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas GFT.DE's P/E ratio is 13.10. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to GFT.DE's ROE of +0.13%. Regarding short-term risk, ADN1.DE is more volatile compared to GFT.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check GFT.DE's competition here
ADN1.DE vs IXX.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, IXX.DE has a market cap of 395.3M. Regarding current trading prices, ADN1.DE is priced at €58.90, while IXX.DE trades at €40.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas IXX.DE's P/E ratio is 27.07. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to IXX.DE's ROE of +0.15%. Regarding short-term risk, ADN1.DE is more volatile compared to IXX.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check IXX.DE's competition here
ADN1.DE vs MCE.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, MCE.DE has a market cap of 232.6M. Regarding current trading prices, ADN1.DE is priced at €58.90, while MCE.DE trades at €14.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas MCE.DE's P/E ratio is -39.17. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to MCE.DE's ROE of -0.10%. Regarding short-term risk, ADN1.DE is more volatile compared to MCE.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check MCE.DE's competition here
ADN1.DE vs AEIN.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, AEIN.DE has a market cap of 193.2M. Regarding current trading prices, ADN1.DE is priced at €58.90, while AEIN.DE trades at €17.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas AEIN.DE's P/E ratio is 112.00. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to AEIN.DE's ROE of -0.00%. Regarding short-term risk, ADN1.DE is more volatile compared to AEIN.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check AEIN.DE's competition here
ADN1.DE vs OSP2.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, OSP2.DE has a market cap of 185.2M. Regarding current trading prices, ADN1.DE is priced at €58.90, while OSP2.DE trades at €18.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas OSP2.DE's P/E ratio is 32.95. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to OSP2.DE's ROE of +0.09%. Regarding short-term risk, ADN1.DE is more volatile compared to OSP2.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check OSP2.DE's competition here
ADN1.DE vs A1OS.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, A1OS.DE has a market cap of 163.8M. Regarding current trading prices, ADN1.DE is priced at €58.90, while A1OS.DE trades at €34.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas A1OS.DE's P/E ratio is 21.46. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to A1OS.DE's ROE of +0.07%. Regarding short-term risk, ADN1.DE is less volatile compared to A1OS.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ADN1.DE.Check A1OS.DE's competition here
ADN1.DE vs 30L3.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, 30L3.DE has a market cap of 134.6M. Regarding current trading prices, ADN1.DE is priced at €58.90, while 30L3.DE trades at €0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas 30L3.DE's P/E ratio is 6.29. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to 30L3.DE's ROE of -0.32%. Regarding short-term risk, ADN1.DE is more volatile compared to 30L3.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check 30L3.DE's competition here
ADN1.DE vs 3IT.F Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, 3IT.F has a market cap of 65.4M. Regarding current trading prices, ADN1.DE is priced at €58.90, while 3IT.F trades at €13.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas 3IT.F's P/E ratio is 19.00. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to 3IT.F's ROE of +0.16%. Regarding short-term risk, ADN1.DE is more volatile compared to 3IT.F. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check 3IT.F's competition here
ADN1.DE vs 3IT.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, 3IT.DE has a market cap of 64.5M. Regarding current trading prices, ADN1.DE is priced at €58.90, while 3IT.DE trades at €13.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas 3IT.DE's P/E ratio is 18.71. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to 3IT.DE's ROE of +0.16%. Regarding short-term risk, ADN1.DE is more volatile compared to 3IT.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check 3IT.DE's competition here
ADN1.DE vs 3ITN.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, 3ITN.DE has a market cap of 58.6M. Regarding current trading prices, ADN1.DE is priced at €58.90, while 3ITN.DE trades at €11.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas 3ITN.DE's P/E ratio is 35.00. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to 3ITN.DE's ROE of +0.16%. Regarding short-term risk, ADN1.DE is more volatile compared to 3ITN.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check 3ITN.DE's competition here
ADN1.DE vs IE2A.F Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, IE2A.F has a market cap of 49.8M. Regarding current trading prices, ADN1.DE is priced at €58.90, while IE2A.F trades at €0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas IE2A.F's P/E ratio is 8.35. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to IE2A.F's ROE of +0.07%. Regarding short-term risk, ADN1.DE is more volatile compared to IE2A.F. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check IE2A.F's competition here
ADN1.DE vs OBS.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, OBS.DE has a market cap of 48.3M. Regarding current trading prices, ADN1.DE is priced at €58.90, while OBS.DE trades at €5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas OBS.DE's P/E ratio is 15.00. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to OBS.DE's ROE of +0.10%. Regarding short-term risk, ADN1.DE is more volatile compared to OBS.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check OBS.DE's competition here
ADN1.DE vs SYT.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, SYT.DE has a market cap of 29.6M. Regarding current trading prices, ADN1.DE is priced at €58.90, while SYT.DE trades at €3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas SYT.DE's P/E ratio is -14.19. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to SYT.DE's ROE of -0.10%. Regarding short-term risk, ADN1.DE is more volatile compared to SYT.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check SYT.DE's competition here
ADN1.DE vs QBY.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, QBY.DE has a market cap of 19.9M. Regarding current trading prices, ADN1.DE is priced at €58.90, while QBY.DE trades at €0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas QBY.DE's P/E ratio is -16.00. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to QBY.DE's ROE of -0.02%. Regarding short-term risk, ADN1.DE is more volatile compared to QBY.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check QBY.DE's competition here
ADN1.DE vs T3T1.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, T3T1.DE has a market cap of 19.2M. Regarding current trading prices, ADN1.DE is priced at €58.90, while T3T1.DE trades at €5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas T3T1.DE's P/E ratio is 16.45. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to T3T1.DE's ROE of +0.15%. Regarding short-term risk, ADN1.DE is more volatile compared to T3T1.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check T3T1.DE's competition here
ADN1.DE vs KSC.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, KSC.DE has a market cap of 14.1M. Regarding current trading prices, ADN1.DE is priced at €58.90, while KSC.DE trades at €0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas KSC.DE's P/E ratio is -0.65. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to KSC.DE's ROE of -0.57%. Regarding short-term risk, ADN1.DE is less volatile compared to KSC.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ADN1.DE.Check KSC.DE's competition here
ADN1.DE vs PDA.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, PDA.DE has a market cap of 11.8M. Regarding current trading prices, ADN1.DE is priced at €58.90, while PDA.DE trades at €2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas PDA.DE's P/E ratio is 30.50. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to PDA.DE's ROE of +0.35%. Regarding short-term risk, ADN1.DE is less volatile compared to PDA.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ADN1.DE.Check PDA.DE's competition here
ADN1.DE vs SHWK.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, SHWK.DE has a market cap of 7.6M. Regarding current trading prices, ADN1.DE is priced at €58.90, while SHWK.DE trades at €3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas SHWK.DE's P/E ratio is -3.34. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to SHWK.DE's ROE of -0.74%. Regarding short-term risk, ADN1.DE is more volatile compared to SHWK.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check SHWK.DE's competition here
ADN1.DE vs AMI.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, AMI.DE has a market cap of 6.9M. Regarding current trading prices, ADN1.DE is priced at €58.90, while AMI.DE trades at €0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas AMI.DE's P/E ratio is -1.74. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to AMI.DE's ROE of -0.29%. Regarding short-term risk, ADN1.DE is less volatile compared to AMI.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ADN1.DE.Check AMI.DE's competition here
ADN1.DE vs RTC.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, RTC.DE has a market cap of 6M. Regarding current trading prices, ADN1.DE is priced at €58.90, while RTC.DE trades at €1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas RTC.DE's P/E ratio is 55.50. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to RTC.DE's ROE of +0.01%. Regarding short-term risk, ADN1.DE is less volatile compared to RTC.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ADN1.DE.Check RTC.DE's competition here
ADN1.DE vs AMI.F Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, AMI.F has a market cap of 5.7M. Regarding current trading prices, ADN1.DE is priced at €58.90, while AMI.F trades at €0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas AMI.F's P/E ratio is -1.43. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to AMI.F's ROE of -0.29%. Regarding short-term risk, ADN1.DE is more volatile compared to AMI.F. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check AMI.F's competition here
ADN1.DE vs PDA0.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, PDA0.DE has a market cap of 3.2M. Regarding current trading prices, ADN1.DE is priced at €58.90, while PDA0.DE trades at €2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas PDA0.DE's P/E ratio is -16.92. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to PDA0.DE's ROE of +0.07%. Regarding short-term risk, ADN1.DE is more volatile compared to PDA0.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check PDA0.DE's competition here
ADN1.DE vs ASKN.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, ASKN.DE has a market cap of 2.4M. Regarding current trading prices, ADN1.DE is priced at €58.90, while ASKN.DE trades at €0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas ASKN.DE's P/E ratio is -0.44. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to ASKN.DE's ROE of +1.04%. Regarding short-term risk, ADN1.DE is less volatile compared to ASKN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ADN1.DE.Check ASKN.DE's competition here
ADN1.DE vs MDV.DU Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, MDV.DU has a market cap of 1.6M. Regarding current trading prices, ADN1.DE is priced at €58.90, while MDV.DU trades at €6.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas MDV.DU's P/E ratio is -71.26. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to MDV.DU's ROE of -0.04%. Regarding short-term risk, ADN1.DE is more volatile compared to MDV.DU. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check MDV.DU's competition here
ADN1.DE vs SFD1.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, SFD1.DE has a market cap of 1.5M. Regarding current trading prices, ADN1.DE is priced at €58.90, while SFD1.DE trades at €0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas SFD1.DE's P/E ratio is -45.00. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to SFD1.DE's ROE of +0.23%. Regarding short-term risk, ADN1.DE is more volatile compared to SFD1.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check SFD1.DE's competition here
ADN1.DE vs EUCA.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, EUCA.DE has a market cap of 990.6K. Regarding current trading prices, ADN1.DE is priced at €58.90, while EUCA.DE trades at €0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas EUCA.DE's P/E ratio is -0.01. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to EUCA.DE's ROE of +2.90%. Regarding short-term risk, ADN1.DE is less volatile compared to EUCA.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ADN1.DE.Check EUCA.DE's competition here
ADN1.DE vs WDL.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, WDL.DE has a market cap of 0. Regarding current trading prices, ADN1.DE is priced at €58.90, while WDL.DE trades at €1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas WDL.DE's P/E ratio is -1.32. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to WDL.DE's ROE of -1.08%. Regarding short-term risk, ADN1.DE is less volatile compared to WDL.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ADN1.DE.Check WDL.DE's competition here
ADN1.DE vs 2QU.DE Comparison April 2026
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 370M. In comparison, 2QU.DE has a market cap of 0. Regarding current trading prices, ADN1.DE is priced at €58.90, while 2QU.DE trades at €17.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of 27.79, whereas 2QU.DE's P/E ratio is N/A. In terms of profitability, ADN1.DE's ROE is +0.07%, compared to 2QU.DE's ROE of -0.11%. Regarding short-term risk, ADN1.DE is more volatile compared to 2QU.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check 2QU.DE's competition here